Clinical Trials Browser

Lymphoma, B-Cell × Gemcitabine × 90 days × Clear all

NCT04161248 2026-05-12

Phase I Master Protocol of Novel Combination Therapy for Patients With Relapsed or Refractory Aggressive B-Cell Lymphoma

Phase EARLY_PHASE1 Active not recruiting

Lymphoma, B-Cell

NCT06230224 2026-05-11

OLYMPIA-4

Phase 3 Active not recruiting

Lymphoma, Non-Hodgkin, Lymphoma, B-Cell